Status:
COMPLETED
Comparison of BIS Index Variations: Bolus Versus Infusion Ketamine, and Impact on the Anesthesia Gas Consumption
Lead Sponsor:
Ciusss de L'Est de l'Île de Montréal
Conditions:
Bolus Versus Infusion Ketamine, Anesthesia Gas Consumption
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The aim of the present study is to show that i.v. ketamine boluses might lead to significant and clinically relevant BIS index increase that might lead to an increase in anesthesia dosing (halogenous ...
Detailed Description
Hypothesis: The investigators hypothesize that BIS will not vary when ketamine is given as an i.v. infusion whereas BIS index will significantly vary when ketamine is given as intraoperative repeated ...
Eligibility Criteria
Inclusion
- ASA I to III
- Patients above 18yo
- Gender female or male
- Abdominal general, urological or gynecological surgery with epidural placement
Exclusion
- BMI \<18 or \>35
- Chronic neurological or psychiatric disorder or history of stroke
- Use of psychotropic drugs within 2 weeks prior surgery
- Allergy to ketamine or its excipients or any drug of the anesthesia protocol of this study
- Any contra-indication or patient's refusal for epidural placement
Key Trial Info
Start Date :
September 25 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03781635
Start Date
September 25 2018
End Date
September 30 2019
Last Update
October 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montreal
Montreal East, Quebec, Canada, H1T2M4